N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
US7662825B2 · kind B2 · utility
1Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2003 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Feb 19, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides N-pyrazinyl-phenyl-sulphonamides of formula (I) for use in the treatment of chemokine mediated diseases. Particularly inflammatory diseases, such as asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.